home / stock / ohrp / ohrp quote
Last: | $ |
---|---|
Change Percent: | 30.19% |
Open: | $4.10 |
Close: | $5.39 |
High: | $5.75 |
Low: | $3.98 |
Volume: | 1,579,642 |
Last Trade Date Time: | 07/12/2019 04:56:45 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $4.10 | $5.39 | $5.75 | $3.98 | 1,579,642 | 07-12-2019 |
$ | $4.02 | $4.14 | $4.22 | $3.82 | 180,314 | 07-11-2019 |
$ | $3.65 | $4.25 | $5.35 | $3.65 | 1,499,718 | 07-10-2019 |
$ | $3.82 | $3.69 | $3.94 | $3.55 | 116,111 | 07-09-2019 |
$ | $3.69 | $3.83 | $4.0602 | $3.51 | 257,192 | 07-08-2019 |
$ | $3.16 | $3.70 | $3.77 | $3.12 | 255,214 | 07-05-2019 |
$ | $3.26 | $3.15 | $3.26 | $3.03 | 43,227 | 07-04-2019 |
$ | $3.26 | $3.15 | $3.26 | $3.03 | 43,227 | 07-03-2019 |
$ | $3.40 | $3.2805 | $3.40 | $3.1266 | 58,848 | 07-02-2019 |
$ | $3.41 | $3.41 | $3.42 | $3.33 | 32,144 | 07-01-2019 |
$ | $3.54 | $3.41 | $3.6999 | $3.38 | 85,094 | 06-28-2019 |
$ | $3.36 | $3.58 | $3.79 | $3.28 | 175,986 | 06-27-2019 |
$ | $3.55 | $3.48 | $3.85 | $3.33 | 122,383 | 06-26-2019 |
$ | $3.65 | $3.55 | $3.65 | $3.50 | 70,174 | 06-25-2019 |
$ | $3.85 | $3.65 | $3.858 | $3.65 | 42,869 | 06-24-2019 |
$ | $3.85 | $3.84 | $4.10 | $3.84 | 46,656 | 06-21-2019 |
$ | $3.92 | $3.78 | $4.10 | $3.70 | 37,149 | 06-20-2019 |
$ | $3.65 | $3.90 | $3.9683 | $3.5901 | 89,475 | 06-19-2019 |
$ | $3.55 | $3.65 | $3.79 | $3.47 | 54,547 | 06-18-2019 |
$ | $3.53 | $3.55 | $3.60 | $3.3578 | 56,158 | 06-17-2019 |
News, Short Squeeze, Breakout and More Instantly...
Ohr Pharmaceutical Inc. Company Name:
OHRP Stock Symbol:
NASDAQ Market:
Ohr Pharmaceutical Inc. Website:
Company expects to initiate trading on NASDAQ Under Ticker Symbol “NBSE” effective July 15, 2019 Company completes previously announced financing of approximately $9 million immediately prior to closing of the merger Greenlight Capital agrees to purchase ~9% of Ne...
NEW YORK, July 10, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (“Ohr”) (Nasdaq: OHRP) today announced that all proposals related to its proposed merger with NeuBase Therapeutics, Inc. (“NeuBase”) were approved by Ohr’s stockholders at a special meeti...
-- Of the Votes Received to Date, More than 99% Are Voting in Favor of the Merger Proposal -- More Votes Are Needed to Reach 50% of the Outstanding Shares to Go Forward with the Special Meeting -- Every Vote Is Important to Avoid Delay in Completion of the Merger NEW YORK, July 03, ...